Published in TB and Outbreaks Week, March 6th, 2007
But developing a vaccine against one of the most talked about types of influenza--the H5, or avian flu--is proving to be more vexing than first thought.
"Making a vaccine for H5 is more difficult than anticipated, even beyond the necessity of making it on the fly," said Harry Greenberg, MD, the Joseph D. Grant Professor at the Stanford University School of Medicine. "At every level...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week